# Kintor Pharmaceutical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kintor-pharmaceutical

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.kintor.com.cn
- Total disclosed funding: $70M
- Latest round: Series C (Jan 12, 2018)
- Investors on record: 8

## About

Established in 2009 and based in Suzhou, China, Kintor Pharmaceutical Limited is a biopharmaceutical company committed to the discovery and development of medicines for the treatment of oncological, cardiovascular, and inflammatory diseases that includes prostate cancer, breast cancer, and liver cancer.

## Funding rounds

- Series C, Jan 12, 2018, $45M — Oriza Holdings, China Construction Bank, Green Pine Capital Partners, Orient Securities Capital, HighLight Capital, Broad Resources, Shanghai Shangchuang Junqiang Investment Managemnt
- Series B, Jul 15, 2015, $10M — HighLight Capital
- Series A, Jul 1, 2012, $16M — Oriza Holdings, Legend Star, HighLight Capital

## Investors

- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series A, Series C
- Legend Star (https://capitalatlas.ai/funds/legend-star) — Series A
- HighLight Capital (https://capitalatlas.ai/funds/highlight-capital) — Series A, Series B, Series C
- China Construction Bank — Series C
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series C
- Orient Securities Capital — Series C
- Broad Resources (https://capitalatlas.ai/funds/broad-resources) — Series C
- Shanghai Shangchuang Junqiang Investment Managemnt — Series C